Don missed an excellent opportunity to put out an IPO for Zenith in late 2019 before the top-line results were announced for RVX, BOM. He would have capitalized on the Apabetalone hype of the sister company Resverlogix and before "ZHCLF" started to trade and take hold on the OTC Market.
IMO ... Koo